Skip to main content
Category

Blog

BlogNewsPress Release
December 7, 2021

Recuro Health Receives Investment by DeepWork Capital and GPG Ventures

Proceeds to Accelerate Growth, Marketing and Expanded Capabilities in Digital Health Recuro Health is proud to announce that the company has received additional investment through its partnerships with DeepWork Capital and GPG Ventures, bringing total raised capital to $22 million. This funding will be used to accelerate Recuro’s growth in key markets and expand commercialization of its integrated digital platform…
BlogNewsPress Release
December 6, 2021

Preparing Employers For COVID-19 OSHA Mandates

Recuro Health Hosts Complimentary Webinar Essential Tools to Help Employers Ensure a Safe and Healthy Workplace Register Now Managing OSHA Mandates for COVID-19 Tracking & Testing Supporting Compliance in the Workplace Tuesday, December 14, 2021 2:00 p.m. – 3:00 p.m. (EST) Webinar registration: https://bit.ly/rc-webinar-register Press Release: https://bit.ly/rc-webinar-dec14 To support employers with insight, guidance and proposed solutions, Recuro Health, in partnership…
BlogMediaNews
October 4, 2021

Recuro Proud to Support 2021 SIIA Annual Meeting: Recuro CEO Michael Gorton Participates on Visionary Panel Exploring Future of Digital Health   

Recuro Proud to Support 2021 SIIA Annual Meeting: Recuro CEO Michael Gorton Participates on Visionary Panel Exploring Future of Digital Health SIIA’s 41st Annual National Educational Conference, October 3-5, 2021, Austin, TX was a great opportunity for Recuro Health to support SIIA and for Recuro’s rollout to employers of its multi-prong digital health solution, including COVID-19 antigen testing and vaccine tracking status capabilities. On a voluntary basis to all attendees, Recuro provided rapid COVID-19 antigen tests and a component to track testing status. A…
Blog
September 24, 2021

Recuro Health Supports SIIA Annual Meeting: Provides Voluntary COVID-19 Antigen Rapid Testing for Attendees: CEO Michael Gorton Panel Presenter

Recuro Health Supports SIIA Annual Meeting: Provides Voluntary COVID-19 Antigen Rapid Testing for Attendees: CEO Michael Gorton Panel Presenter Recuro Health is proud to support the SIIA annual conference by providing COVID-19 antigen rapid tests on a voluntary basis to all attendees during the three-day conference: SIIA’s 41st Annual National Educational Conference, October 3-5, 2021, Austin, TX. Recuro’s COVID-19 rapid…
Blog
September 7, 2021

Recuro Health Raises $15 million in Series A Round Led by ARCH Venture Partners to Fund Next Generation of Digital Health Solutions

Recuro Health Raises $15 million in Series A Round Led by ARCH Venture Partners to Fund Next Generation of Digital Health Solutions At Recuro, we are always looking for ways to expand digital health solutions capabilities. That’s why we raised an oversubscribed seed-round fund in March 2021 and just five months later, announced a new $15 million Series A financing…
Blog
August 25, 2021

Recuro’s At-Home & Onsite COVID Testing Solution Can Ensure Workplace Safety as Delta Variant Cases Grow 

The Centers for Disease Control and Prevention (CDC) estimates that the Delta variant represents about 99% of new COVID-19 infections. As a result, there is a sharp, increased demand for COVID At-Home or Onsite Testing solutions. Employers recognize that frequent or ongoing testing can ensure a safe return-to-work and employee participation at crucial meetings, events and conventions. An avalanche of requests…
Blog
August 2, 2021

Delta Variant, Stalled Vaccination Rates, New Directives from Federal/State Governments, CDC and Employers Increase Demand for Recuro’s At-Home & In-office COVID Testing Solution

‘Vaccinate or Get Tested’ is the new policy from all corners of government and private industry amid the surge of the Delta variant, recurrence of disease even among those who have been vaccinated and a plateau in vaccination rates. Testing often is rapidly being adopted across the country as a key to stopping the virus spread. But fulfilling these directives requires employers…
Blog
July 26, 2021

Recuro’s At-Home Testing Expert Shares “Best Practices” and Industry Future at American Telemedicine Association’s 2021 Conference

Allison Martin, a founder and executive director of Recuro Health, recently joined a panel at the American Telemedicine Association’s annual conference to talk about emerging tech for lingering gaps in virtual care and exploring remote testing and diagnostics in the home. Recuro’s at-home diagnostic and health screening software platform is designed to personalize the at-home testing experience. Its COVID-19 rapid…
Blog
July 20, 2021

Recuro Acquires Genomics Risk Stratification Tool: Expanding Capabilities for Personalized Care and Streamlining Full Continuum of Care

Genetic testing has been available for several years. Consumer genomics is very popular now with the medically focused use of genetic testing growing rapidly at the same time. In 2020, the genetic marketing trend exceeded $14.8 billion and is expected to have a 11-13% annual growth rate in 2021-2027. The industry’s growth is attributable to the increasing prevalence of chronic…
Blog
June 30, 2021

Recuro Health’s Digital Solutions Promote Integration of Behavioral and Physical Health, More Personalized and Convenient Care

Mental health was taboo. The subject was dodged in social circles, sidestepped in the media and completely avoided in the workplace. But awareness has grown. Increasingly, people recognize that both physical and mental health are critical to a person’s overall well-being. You can’t ignore one and expect high marks on the other. There’s significant upside to reducing the stigma around…